TIP24-199: Rhenium (Re-186) Obisbemeda {Re-186-nanoliposome (186RNL)} in Leptomeningeal Metastases [LM] Phase 1/2A Dose Escalation Trial: Update of Initial Safety and Feasibility Through Cohorts 1–4

Norman LaFrance, Andrew Brenner,Priya Kumthekar,Michael Youssef,Ande Bao,Melissa M. Moore,Joel E. Michalek, Marc H. Hedrick,William T. Phillips,Toral Patel,Jeffrey S. Weinberg, John R. Floyd

Journal of the National Comprehensive Cancer Network（2024）

引用 0|浏览0

暂无评分

摘要

"TIP24-199: Rhenium (Re-186) Obisbemeda {Re-186-Nanoliposome (186RNL)} in Leptomeningeal Metastases [LM] Phase 1/2A Dose Escalation Trial: Update of Initial Safety and Feasibility Through Cohorts 1–4" published on 05 Apr 2024 by National Comprehensive Cancer Network.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要